Objective: To determine which parameters of body composition or metabolism best correlate with changes in 24 h ghrelin levels following weight loss. Design: A 3-month low-calorie diet followed by 3 months of weight stabilization. Subjects: Twelve overweight and obese adult men and women. Measurements: Body composition by underwater weighing, abdominal fat depots, leptin, ghrelin and parameters of insulin and lipid metabolism. Results: Increased 24 h ghrelin levels after weight loss correlated with decreases in body mass index, subcutaneous fat and fatfree mass (FFM), but not with changes in fat mass, fat cell size, leptin, insulin, insulin sensitivity, lipids or free fatty acid levels. The change in FFM correlated with the rise in ghrelin levels independently of body adiposity. Discussion: Alterations in FFM with diet-induced weight loss may play a role in ghrelin regulation. Changes in ghrelin levels could, then, serve as an integrative signal reflecting changes in FFM to hypothalamic centers controlling energy homeostasis.
Introduction
Changes in circulating levels of the gut-derived hormone ghrelin occur in relation to changes in body weight in humans. Evidence for this comes from studies demonstrating higher levels of ghrelin in subjects with cachexia, 1 in underweight patients with anorexia nervosa 2 and increases in ghrelin levels following diet-induced weight loss. 3, 4 Because ghrelin is an orexigenic hormone, these changes may help to restore body weight to baseline in obese subjects following periods of caloric restriction. It is not known which component or components of body composition or metabolism are sensed by systems that regulate ghrelin levels during alterations in energy balance. It is unlikely that caloric reduction alone would cause a rise in ghrelin levels as a recent study has demonstrated that ghrelin levels increase in response to exercise-induced weight loss in postmenopausal women despite a stable caloric intake. 5 It is possible that the rise in ghrelin following diet-induced weight loss may reflect changes in body composition (including changes in fat or lean mass), glucose or lipid metabolism or some combination of these, as all of these parameters have been associated with ghrelin levels in crosssectional studies. [6] [7] [8] A leading candidate in the regulation of ghrelin levels is insulin. Insulin and ghrelin levels correlate inversely with one another both in the fasting state and in response to meals. 3, [8] [9] [10] Although the results of insulinclamp studies have been controversial, in one study insulin was shown to be necessary for post-prandial ghrelin suppression in humans, 11 and in another, ghrelin levels were suppressed during a high-dose insulin infusion. 12 On the other hand, given the close relationship between insulin levels and insulin sensitivity, and the fact that insulin resistance is also associated with lower ghrelin levels, 8 it is possible that the improved insulin sensitivity with weight loss leads to increased ghrelin levels. In addition, we have recently shown that high-density lipoprotein (HDL) cholesterol levels are positively correlated with ghrelin levels. 8 As ghrelin can bind to HDL particles, 13 increases in HDL levels after weight loss could account for a portion of the rise in ghrelin levels. The present study was therefore undertaken to determine which changes in measures (alone or in combination) of specific body composition, glucose metabolism and lipid levels predict the rise in ghrelin with diet-induced weight loss in humans.
Materials and methods
Subjects were recruited through advertising in local newspapers and on the campus of the University of Washington, were at least 18 years old, were at their lifetime maximal body weight and had been stable at this body weight for at least 3 months as previously described. 3 The Human Subjects
Review Committee at the University of Washington approved all procedures and protocols; informed consent was obtained from all subjects before the enrollment. Thirteen obese subjects (eight women and five men, mean7s.d. body mass index (BMI) 35.671.6 kg/m 2 , mean7s.d. age 42.9.672.4 years) received a liquid-formula diet of 1000 kcal per day for 3 months. Participants then underwent a gradual transition over the course of 2 weeks to a solid diet containing 30% fat, 15% protein and 55% carbohydrates. During the subsequent 3 months of weight stabilization, the total number of calories was adjusted to maintain body weight and participants were instructed as how to continue this level of caloric restriction at home.
Before beginning the 3 months of weight loss and again following the 3 months of weight stabilization (6 months total), subjects were admitted to the General Clinical Research Center (GCRC) for 48-h following an overnight fast. Blood was withdrawn for measurement of baseline blood samples, followed by a tolbutamide-modified frequently sampled intravenous glucose-tolerance test (FSIVGTT) to determine insulin sensitivity. 14 The following day, beginning at 0800 h after another overnight fast, blood was then collected in ethylenediaminetetraacetic acid tubes every 30 min for 24 h in all to measure ghrelin levels. Samples were stored at 41C during the collection period, after which plasma was stored at À801C. Percent body fat was measured by underwater weighing, 15 the volumes of subcutaneous (SQF) and intra-abdominal (IAF) fat were assessed by a single-computed tomography image obtained at the level of the umbilicus, 16 and the adipocyte volume was determined by applying Goldrick's equation 17 to the measured diameters of 400 adipocytes aspirated from the posterior superior iliac-crest region.
Plasma total cholesterol, triglyceride, low-density lipoprotein (LDL) cholesterol and HDL cholesterol were measured as described previously. 18, 19 Total plasma immunoreactive ghrelin was measured in duplicate with a commercial radioimmunoassay (Phoenix Pharmaceuticals, Inc., Belmont, CA, USA). The intra-assay coefficient of variation for the ghrelin assay was 6.9% and the inter-assay coefficient of variation was 12%. Mean fasting-free fatty acids were measured from three separate blood samples obtained 5 min apart using a commercial assay (Wako Chem. USA, Inc., Richmond, VA, USA) in the same assay. The intra-assay coefficient of variation of this assay ranges between 1.1 and 2.7%. Area-under-the-curve (AUC) ghrelin levels for the entire 24 h were calculated using the trapezoidal method. Correlational relationships were tested using linear regression or multiple linear regression analysis. When appropriate, nonnormally distributed variables were natural log transformed before performing linear regression analysis. A Pp0.05 was considered significant.
Results
The average weight loss was 17 kg (17% compared with baseline) (Table 1 ). Both fat mass and fat-free mass decreased, but proportionally more weight was lost in fat mass (34%) than in fat-free mass (5%) ( Table 1) . Levels of leptin and insulin decreased 36 and 31%, respectively, whereas AUC ghrelin levels rose 30%, all Po0.01 (Table 1) Ghrelin and fat-free mass after weight loss JQ Purnell et al
In single-variable regression analysis of the 12 subjects who experienced an increase in 24-h AUC ghrelin (Table 2) , this increase (dependent variable) was associated with the decrease in BMI and abdominal SQF, but not changes in percent body fat, IAF, fat cell size, leptin levels, lipid levels (including HDL), free fatty acids, fasting insulin or insulin sensitivity. When measurements of body composition were analyzed separately, the increase in 24-h AUC ghrelin was associated with the decrease in fat-free mass, but not fat mass (Table 2) .
On multiple linear regression analysis with the change in 24-h AUC ghrelin values as the dependent variable and the change in BMI, SQF and fat-free mass as the independent variables, only the change in fat-free mass was significantly associated with the change in ghrelin levels (Model 1, Table 3 ). Because of co-linearity between BMI and SQF, associations of these measurements with the incremental increase in AUC ghrelin levels were individually tested with fat-free mass as independent variables (Models 2 and 3, Table 3 ). In these models, fat-free mass remained independently associated with the change in 24-h ghrelin levels (Table 3) , although BMI and SQF also became significantly associated as well.
Discussion
The increase in ghrelin levels that accompanies low-calorie diet-induced weight loss may act as a compensatory signal to restore body weight to baseline. If so, then the rise in ghrelin may be a response to a change in metabolic or hormonal signals reflecting weight loss or an alteration in body composition, not just a reduction in food intake. 5 In crosssectional studies, ghrelin levels are associated with BMI, fat cell size, insulin, insulin sensitivity and HDL cholesterol. 6, 8, 20 Therefore, the present study sought to determine which metabolic, hormonal or body composition variables were associated with the increase in ghrelin levels in a well-characterized group of subjects undergoing dietinduced weight loss. We have previously shown improvements in body composition, abdominal fat distribution, fat-cell size, insulin sensitivity and lipid levels (total and LDL cholesterol, but not HDL cholesterol), after 3 months of weight loss followed by 3 months of weight stabilization in the group of men and women included in this study. 3 We now report that the rise in daily ghrelin levels was strongly associated with the fall in BMI as well as SQF, but not with reductions in IAF or fat cell size. Surprisingly, this rise in daily ghrelin levels was not associated with changes in fat mass, insulin levels, insulin sensitivity, free fatty acid levels or HDL levels. Instead, the best correlate was change in fat-free mass. Using multiple linear regression analysis, after including the decreases in BMI and SQF, together or separately, the decrease in fat-free mass remained the most significant independent correlate of the incremental increase in 24-h AUC ghrelin levels. Another recent study of overweight and obese men and women who included AUC measurements of ghrelin after a single meal also found that the incremental change in postprandial AUC ghrelin following a low-calorie diet induced weight loss best correlated with changes in lean mass. 21 Our data extend the association to include ghrelin levels over the entire 24 h (not just fasting or post-prandial levels) and show that it remains independent of other measurements of body composition and metabolic control. Interestingly, subjects with Prader-Willi syndrome (PWS) have an unusually low lean mass in proportion to their fat mass 22 and uniquely high ghrelin levels among obese subjects. [23] [24] [25] It has recently been shown that the elevation in their ghrelin levels cannot be fully explained by their Ghrelin and fat-free mass after weight loss JQ Purnell et al insulin resistance. 26 Our data suggest that the low lean mass typically found in PWS subjects could potentially be a cause of, or have a direct relationship with, the elevated ghrelin levels in this population. If ghrelin levels rise in response to decreases in fat-free mass, this could be due to direct or indirect mechanisms. Fatfree mass, as measured by underwater weighing primarily consists of muscle but also includes bone and organ tissue such as the liver and kidneys. With weight loss, however, a loss of muscle mass accounts for most of the change in fatfree mass. A direct signal from muscle that affects ghrelin levels might be secreted in proportion to muscle mass, transported in the blood and affect ghrelin secretion or clearance. Alternatively, an indirect mechanism might include changes in hormonal or inflammatory signals not measured here, or alternatively, in parasympathetic nervous system signaling that accompany weight loss. 27, 28 In conclusion, in this preliminary study, the rise in ghrelin levels after diet-induced weight loss correlated best with the fall in fat free mass and not with changes in fat-mass, insulin levels, or insulin sensitivity. If this finding is replicated in larger studies, then two intriguing possibilities are raised. The first is that changes in ghrelin levels are somehow able to reflect, directly or indirectly, alterations in fat-free mass. The second is that ghrelin may act as an 'integrating' signal to central systems coordinating weight regulation, reflecting fat-free mass along with the adiposity signals such as leptin.
